- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03284450
Exercise Induced Muscle Damage Post Dance and Sprint Specific Exercise in Females
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Twenty nine female recreational dancers from a University dance team volunteered to take part in the study. A 3-day food diary and activity log completed prior to testing determined that there were no differences in physical activity levels or energy and macronutrient intakes between participants. Subjects were asked to replicate their reported diets as closely as possible throughout the testing period. A menstrual cycle questionnaire was also completed in order to determine menstrual cycle phase; all testing took place during the early/mid luteal phase.
Participants were randomly assigned to two exercise groups designed to induce EIMD; either a dance-specific protocol (DPFT) or a sport-specific repeated sprint protocol (SSRS). Participants completed the DPFT (n=15) or SSRS (n=14) and a battery of commonly used muscle damage indices were measured pre, immediately post and 24-, 48-, and 72 h post muscle damage. These were; delayed onset muscle soreness (DOMS), limb girth, countermovement jump height (CMJ), reactive strength index (RSI), maximal voluntary isometric contraction (MVC) sprint performance, and total creatine kinase (CK) activity. Participants were tested at the same time on subsequent days (± 1 h) to account for diurnal variation. Participants were asked to avoid strenuous exercise, alcohol, caffeine, nutritional supplements and any anti-inflammatory drugs or alternative treatments for the duration of the study.
Statistical software (IBM SPSS v21, IBM, USA) was used for inferential analysis and significance was accepted at the P < .05 a priori. Mauchley's test assessed the sphericity of the data and where appropriate, violations were corrected using the Greenhouse-Geisser. To explore our first objective, a one-way analysis of variance (ANOVA) with repeated measures (group, 1; time, 5) was performed on all variables in order to analyse the muscle damage response to the DPFT. For the second aim a two-way ANOVA with repeated measures (group, 2; time, 5) was used for all variables to allow for comparison of the muscle damage response between the DPFT and the SSRS. Where appropriate LSD post-hoc analysis was performed.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- physically active
- at least 3 years experience in dance training
Exclusion Criteria:
- presence of any medical or physical conditions, either chronic or sustained in the last 3 months which would make participation difficult or harmful to the participant
- eg. history of cardiovascular disease and musculoskeletal disorders
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Dance performance fitness test (DPFT)
|
The DPFT described previously (Redding et al., 2009) involves the repetition of a 'dance phrase' representative of contemporary dance, with each phrase separated by a 2 minute rest period.
For the present study the originally described test was extended; the adapted protocol involved 10 x 1 minute movement phrases, each separated by 2 minutes rest.
|
Active Comparator: Sport specific repeated sprints (SSRS)
|
The SSRS (Howatson & Milak, 2009) involved 15 x 30 m sprints with a rapid 10 m deceleration phase, with each sprint departing every 65 seconds.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in maximum voluntary contraction (MVC)
Time Frame: Change from pre exercise MVC at 24 h post exercise
|
Isometric MVC of the participants' dominant knee extensors was assessed using a strain gauge.
|
Change from pre exercise MVC at 24 h post exercise
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Limb girths
Time Frame: pre, immediately post (0) and 24-, 48-, and 72 h post exercise
|
Lower limb girths at the calf and mid-thigh of the right leg were recorded as measures of muscle swelling.
Both locations were marked with permanent marker to ensure consistency on consecutive days.
|
pre, immediately post (0) and 24-, 48-, and 72 h post exercise
|
Countermovement jump
Time Frame: pre, immediately post (0) and 24-, 48-, and 72 h post exercise
|
Countermovement jump height was recorded using a light timing system.
|
pre, immediately post (0) and 24-, 48-, and 72 h post exercise
|
Reactive strength index
Time Frame: pre, immediately post (0) and 24-, 48-, and 72 h post exercise
|
Participants performed a drop jump from a 30cm height to determine reactive strength index
|
pre, immediately post (0) and 24-, 48-, and 72 h post exercise
|
Muscle soreness
Time Frame: pre, immediately post (0) and 24-, 48-, and 72 h post exercise
|
Subjective muscle soreness was measured using a 200 mm visual analogue scale from 'no soreness' to 'unbearably sore.' Participants were required to indicate on the line the level of perceived active lower limb soreness felt during a 90 degree squat.
|
pre, immediately post (0) and 24-, 48-, and 72 h post exercise
|
30 m sprint time
Time Frame: pre, immediately post (0) and 24-, 48-, and 72 h post exercise
|
Participants completed a single maximal effort 30 m sprint where sprint time was recorded.
The sprint was initiated from a line 30 cm behind the start line in order to prevent false triggering of the timing gates.
|
pre, immediately post (0) and 24-, 48-, and 72 h post exercise
|
Creatine Kinase
Time Frame: pre, immediately post (0) and 24-, 48-, and 72 h post exercise
|
Blood samples were collected via venepuncture from the antecubital fossa area in to a 10 ml EDTA vacutainer.
The samples were centrifuged at 3000 RCF for 15 minutes at 4 C. Plasma was extracted, and stored immediately at -80 C for later analysis.
Plasma CK concentrations were determined spectrophotometrically.
|
pre, immediately post (0) and 24-, 48-, and 72 h post exercise
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Emma J Stevenson, PhD, Northumbria University
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Exercise Induced Muscle Damage
-
St Mary's University CollegeNot yet recruitingExercise Induced Muscle Damage
-
Swiss Federal Institute of TechnologyCompletedExercise Induced Muscle DamageSwitzerland
-
Northumbria UniversityCompletedExercise-induced Muscle Damage is Reduced in Resistance Trained Athletes by Branch Chain Amino AcidsExercise-induced Muscle Damage
-
St Mary's University CollegeCompletedExercise-induced Muscle DamageUnited Kingdom
-
Federal University of Health Science of Porto AlegreCompletedFatigue | Exercise-induced Muscle DamageBrazil
-
Université de MontréalCompletedExercise | Nutrition | Damage MuscleCanada
-
University of ThessalyCompletedSkeletal Muscle Performance | Skeletal Muscle Damage | Exercise-induced Aseptic Inflammation | Antioxidant StatusGreece
-
University of ThessalyCompletedSkeletal Muscle Performance | Skeletal Muscle Damage | Exercise-induced Aseptic Inflammation | Intracellular Signaling in Skeletal Muscle | Proteasome ActivationGreece
-
University of ThessalyCompletedPerformance | Skeletal Muscle Damage | Exercise-induced Aseptic InflammationGreece
-
Mucos Pharma GmbH & Co. KGCompletedMuscle Soreness | Muscle Injury | Exercise Induced Muscle DamageGermany